Oncologist
Involving hospitalists in inpatient care improves patient outcomes, oncologist experience
Enlisting hospitalists in the co-management of patients with cancer reduced hospital length of stay, increased hospital capacity for new inpatients and reduced stress among oncologists, according to a study in Journal of Hospital Medicine.
Rheumatology, oncology teamwork crucial to assess checkpoint inhibitor 'risks, benefits'
Collaboration between oncologists and rheumatologists is essential to curtail the increasing prevalence immune-related adverse events linked to checkpoint inhibitor therapy, according to a presenter here.
Oncologist could be next FDA commissioner nominee
The Trump administration is expected to announce that Stephen M. Hahn, MD, chief medical executive and professor of radiation oncology at The University of Texas MD Anderson Cancer Center, is the next FDA commissioner, according to reporting by The Wall Street Journal.
Managing adverse events from checkpoint inhibitors in a ‘data-free zone’
SAN DIEGO — Increasing use of checkpoint inhibitors in cancer therapy is leading to an uptick in immune-related adverse events for rheumatologists to manage, according to a presentation at the Congress of Clinical Rheumatology West.